Skip to main content

Author: Craig Boerner

Potential Rett syndrome drug shows promising results in phase 3 trial

Dec. 6, 2021—A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.

Read more


Case to depart role as Chief Compliance Officer

Nov. 17, 2021—Vanderbilt University Medical Center Chief Compliance Officer Edward (Ted) Case, JD, is leaving VUMC to return to private law practice.

Read more


Raman, Balucan receive health equity research grants

Sep. 9, 2021—Vanderbilt researchers Rameela Raman, PhD, and Francis Balucan, MD, MBA, are the recipients of the first annual Vanderbilt Center for Health Services Research (CHSR) Health Equity Research Grants.

Read more


VUMC, NIH launch clinical trial to test novel therapies to protect host tissue against COVID-19

Jul. 26, 2021—Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.

Read more


COVID-19 pandemic brought changes in cigarette smoking: study

Jun. 9, 2021—Smokers who believed they were at increased risk of getting COVID-19 during the pandemic, or having a more severe case, were more likely to quit while those whoperceived more stress increased smoking, according to new research published in the Journal of General Internal Medicine.

Read more


Type 2 diabetes medication shown to benefit asthma patients

May. 20, 2021—Type 2 diabetes patients who also have asthma are benefitting from a diabetes medication, typically given to help the pancreas produce more insulin, that also improves asthma symptoms and may reduce lung and airway inflammation.

Read more


Heparin, platelets discouraged as treatment for blood clots after COVID vaccine

May. 12, 2021—Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.

Read more


Preterm births in Tennessee decreased during pandemic

Mar. 15, 2021—Statewide stay-at-home orders put in place as Tennessee fought to control the spread of coronavirus last March were associated with a 14% lower rate of preterm birth, according to a research letter published today in JAMA Pediatrics.

Read more


Stimulation device helps patients with bladder disorders reprogram

Mar. 8, 2021—A neurostimulator surgically implanted above the buttocks to reprogram how the bladder senses the filling of urine is helping patients with debilitating bladder and bowel disorders that are often life-limiting.

Read more


Study shows drastic increases in opioid-affected births

Jan. 12, 2021—The rate of mothers who had an opioid-related diagnosis when delivering their baby increased by 131% from 2010-2017, as the incidence of babies diagnosed with drug withdrawal, known as neonatal abstinence syndrome (NAS), increased by 82% nationally during that same time period.

Read more


Autism theory 25 years in the making

Jan. 8, 2021—A unifying explanation of the cause of autism and the reason for its rising prevalence has eluded scientists for decades, but a theoretical model published in the journal Medical Hypotheses describes the cause as a combination of socially valued traits, common in autism, and any number of co-occurring disabilities.

Read more


Statins to be studied for prevention of dementia, disability and heart disease 

Nov. 17, 2020—Vanderbilt University Medical Center (VUMC) researchers are enrolling adults aged 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more